These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 32048037)

  • 1. Intractable hepatic encephalopathy in cirrhotic patients: mid-term efficacy of balloon-occluded retrograde portosystemic shunt obliteration.
    Mukund A; Chalamarla LK; Singla N; Shasthry SM; Sarin SK
    Eur Radiol; 2020 Jun; 30(6):3462-3472. PubMed ID: 32048037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of balloon-occluded retrograde transvenous obliteration of large spontaneous lienorenal shunt in patients with severe recurrent hepatic encephalopathy with foam sclerotherapy: initial experience.
    Mukund A; Rajesh S; Arora A; Patidar Y; Jain D; Sarin SK
    J Vasc Interv Radiol; 2012 Sep; 23(9):1200-6. PubMed ID: 22832139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and Efficacy of Sodium Tetradecyl Sulfate and Lipiodol Foam in Balloon-Occluded Retrograde Transvenous Obliteration (BRTO) for Large Porto-Systemic Shunts.
    Mukund A; Deogaonkar G; Rajesh S; Shasthry SM; Sarin SK
    Cardiovasc Intervent Radiol; 2017 Jul; 40(7):1010-1016. PubMed ID: 28180928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of Balloon-Occluded Retrograde Transvenous Obliteration (BRTO) Using Ethanolamine Oleate (EO), BRTO Using Sodium Tetradecyl Sulfate (STS) Foam and Vascular Plug-Assisted Retrograde Transvenous Obliteration (PARTO).
    Kim YH; Kim YH; Kim CS; Kang UR; Kim SH; Kim JH
    Cardiovasc Intervent Radiol; 2016 Jun; 39(6):840-6. PubMed ID: 26757912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liver stiffness measured by transient elastography as predictor of prognoses following portosystemic shunt occlusion.
    Ishikawa T; Sasaki R; Nishimura T; Matsuda T; Maeda M; Iwamoto T; Saeki I; Hidaka I; Takami T; Sakaida I
    J Gastroenterol Hepatol; 2019 Jan; 34(1):215-223. PubMed ID: 30070412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent development of balloon-occluded retrograde transvenous obliteration.
    Kobayakawa M; Ohnishi S; Suzuki H
    J Gastroenterol Hepatol; 2019 Mar; 34(3):495-500. PubMed ID: 30170340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term results of balloon-occluded retrograde transvenous obliteration for gastric fundal varices: hepatic deterioration links to portosystemic shunt syndrome.
    Kumamoto M; Toyonaga A; Inoue H; Miyakoda K; Morita Y; Emori K; Sakamoto Y; Oho K; Sata M
    J Gastroenterol Hepatol; 2010 Jun; 25(6):1129-35. PubMed ID: 20594229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma Glucose Level Is Predictive of Serum Ammonia Level After Retrograde Occlusion of Portosystemic Shunts.
    Ishikawa T; Aibe Y; Matsuda T; Iwamoto T; Takami T; Sakaida I
    AJR Am J Roentgenol; 2017 Sep; 209(3):W169-W176. PubMed ID: 28657848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of Transjugular Intrahepatic Portosystemic Shunt with Covered Stent and Balloon-Occluded Retrograde Transvenous Obliteration in Managing Isolated Gastric Varices.
    Kim SK; Lee KA; Sauk S; Korenblat K
    Korean J Radiol; 2017; 18(2):345-354. PubMed ID: 28246514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-Term Outcomes of Balloon-Occluded Retrograde Transvenous Obliteration for the Treatment of Gastric Varices: A Comparison of Ethanolamine Oleate and Sodium Tetradecyl Sulfate.
    Chu HH; Kim M; Kim HC; Lee JH; Jae HJ; Chung JW
    Cardiovasc Intervent Radiol; 2018 Apr; 41(4):578-586. PubMed ID: 29264640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis C virus-associated decompensated liver cirrhosis with refractory hepatic encephalopathy successfully treated by balloon-occluded retrograde transvenous obliteration after sofosbuvir/velpatasvir.
    Takakusagi S; Shimizu M; Yokoyama Y; Kizawa K; Marubashi K; Kosone T; Sato K; Kakizaki S; Takagi H; Uraoka T
    Clin J Gastroenterol; 2020 Dec; 13(6):1303-1309. PubMed ID: 32914297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful control of portal hypertension-related complications after two embolization procedures for multiple and large spontaneous portosystemic shunts in a patient with liver cirrhosis.
    Ueno W; Sato N; Miura K; Morimoto N; Watanabe S; Nomoto H; Isoda N; Kijima S; Kikuchi T; Manaka S; Mori H; Yamamoto H
    Clin J Gastroenterol; 2021 Aug; 14(4):1227-1232. PubMed ID: 33993428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Balloon-occluded retrograde transvenous obliteration versus transjugular intrahepatic portosystemic shunt for treatment of gastric varices due to portal hypertension: A meta-analysis.
    Wang YB; Zhang JY; Gong JP; Zhang F; Zhao Y
    J Gastroenterol Hepatol; 2016 Apr; 31(4):727-33. PubMed ID: 26637789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Balloon-occluded retrograde transvenous obliteration improves liver function in patients with cirrhosis and portal hypertension.
    Miyamoto Y; Oho K; Kumamoto M; Toyonaga A; Sata M
    J Gastroenterol Hepatol; 2003 Aug; 18(8):934-42. PubMed ID: 12859723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bleeding gastric varices obliteration with balloon-occluded retrograde transvenous obliteration using sodium tetradecyl sulfate foam.
    Sabri SS; Swee W; Turba UC; Saad WE; Park AW; Al-Osaimi AM; Caldwell SH; Matsumoto AH; Angle JF
    J Vasc Interv Radiol; 2011 Mar; 22(3):309-16; quiz 316. PubMed ID: 21353984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of balloon-occluded retrograde transvenous obliteration with ethanolamine oleate for the treatment of hepatic encephalopathy in a cirrhotic patient with a large spontaneous splenorenal shunt.
    Numata K; Tanaka K; Kiba T; Saito S; Shirato K; Kitamura T; Sekihara H
    J Gastroenterol; 1998 Jun; 33(3):424-7. PubMed ID: 9658325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Shunt occlusion for portosystemic shunt syndrome related refractory hepatic encephalopathy-A single-center experience in 21 patients from Kerala.
    Philips CA; Kumar L; Augustine P
    Indian J Gastroenterol; 2017 Sep; 36(5):411-419. PubMed ID: 29124669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of different coils for endovascular coiling for intractable hepatic encephalopathy caused by a portosystemic shunt.
    Ishikawa T; Imai M; Endo S; Azumi M; Nozawa Y; Iwanaga A; Sano T; Honma T; Yoshida T
    Ann Palliat Med; 2022 Jun; 11(6):1954-1960. PubMed ID: 35073712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Results of Portosystemic Shunt Embolization in Selected Patients with Cirrhosis and Recurrent Hepatic Encephalopathy.
    Choudhary NS; Baijal SS; Saigal S; Agarwal A; Saraf N; Khandelwal R; Jain V; Khandelwal AH; Kapoor A; Jain D; Misra SR; Puri R; Sud R; Soin AS
    J Clin Exp Hepatol; 2017 Dec; 7(4):300-304. PubMed ID: 29234193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Balloon-occluded antegrade transvenous obliteration with or without balloon-occluded retrograde transvenous obliteration for the management of gastric varices: concept and technical applications.
    Saad WE; Kitanosono T; Koizumi J
    Tech Vasc Interv Radiol; 2012 Sep; 15(3):203-25. PubMed ID: 23021832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.